• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[局限性和局部进展性肾细胞癌:预后评估方法]

[Localized and locally advanced renal cell carcinoma: method of outcome prognosis].

作者信息

Serniak Iu P

出版信息

Urol Nefrol (Mosk). 1998 Jan-Feb(1):32-5.

PMID:9532944
Abstract

Basing on the long-term results of nephrectomy in 180 patients with renal cell carcinoma, the detailed assessment has been made of implications of a number of factors in 5-year survival and contribution of these factors to the disease outcome. The author proposes a method of prognosticating the disease outcome in patients with localized and locally advanced renal carcinoma which enables specification of the existing international classification and more precise prognosis of the disease. At stages T2, T3 and T4, 5-year survival reached in the subgroups with good prognosis 74.1, 100, and 30.8% of patients, respectively; with poor prognosis 7.1, 5.3, and 0%, respectively. Prognostic subgroup of the patient should be considered in the design of the treatment scheme.

摘要

基于180例肾细胞癌患者肾切除术的长期结果,对若干因素对5年生存率的影响以及这些因素对疾病结局的作用进行了详细评估。作者提出了一种预测局限性和局部进展性肾癌患者疾病结局的方法,该方法能够细化现有的国际分类并更精确地预测疾病。在T2、T3和T4期,预后良好的亚组患者5年生存率分别达到74.1%、100%和30.8%;预后不良的亚组分别为7.1%、5.3%和0%。在设计治疗方案时应考虑患者的预后亚组。

相似文献

1
[Localized and locally advanced renal cell carcinoma: method of outcome prognosis].[局限性和局部进展性肾细胞癌:预后评估方法]
Urol Nefrol (Mosk). 1998 Jan-Feb(1):32-5.
2
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.肾切除术后非转移性肾细胞癌四种预后模型预测准确性的比较:一项欧洲多中心研究
Cancer. 2005 Oct 1;104(7):1362-71. doi: 10.1002/cncr.21331.
3
Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.肾切除术后孤立性肾细胞癌窝复发的结局
J Urol. 2000 Aug;164(2):322-5.
4
Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.基于TNM分类的肾细胞癌术前预后列线图(概率表)。
J Urol. 2009 Feb;181(2):480-5; discussion 485. doi: 10.1016/j.juro.2008.10.017. Epub 2008 Dec 19.
5
Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma.局限性肾细胞癌肿瘤肾切除术后患者肿瘤大小的预后意义。
Eur Urol. 2004 Sep;46(3):327-30. doi: 10.1016/j.eururo.2004.06.003.
6
Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.T4NxM1期肾细胞癌的减瘤性肾切除术:MD安德森癌症中心的经验
Urology. 2007 May;69(5):835-8. doi: 10.1016/j.urology.2007.01.034.
7
Does stage T3a renal cell carcinoma embrace a homogeneous group of patients?T3a期肾细胞癌患者群体是否具有同质性?
J Urol. 2007 May;177(5):1682-6. doi: 10.1016/j.juro.2007.01.064.
8
Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.非透明细胞组织学类型的转移性肾细胞癌的减瘤性肾切除术。
J Urol. 2007 Nov;178(5):1896-900. doi: 10.1016/j.juro.2007.07.037. Epub 2007 Sep 17.
9
Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.转移性肾细胞癌肺切除术后的预后因素与生存情况
Eur Urol. 2005 Jul;48(1):77-81; discussion 81-2. doi: 10.1016/j.eururo.2005.03.004. Epub 2005 Mar 20.
10
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.肿瘤大小不能预测小肾癌的转移风险或预后。
J Urol. 2008 May;179(5):1719-26. doi: 10.1016/j.juro.2008.01.018. Epub 2008 Mar 17.